BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 26311743)

  • 1. Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.
    Heerma van Voss MR; Vesuna F; Trumpi K; Brilliant J; Berlinicke C; de Leng W; Kranenburg O; Offerhaus GJ; Bürger H; van der Wall E; van Diest PJ; Raman V
    Oncotarget; 2015 Sep; 6(29):28312-26. PubMed ID: 26311743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Henryin, an ent-kaurane diterpenoid, inhibits Wnt signaling through interference with β-catenin/TCF4 interaction in colorectal cancer cells.
    Li X; Pu J; Jiang S; Su J; Kong L; Mao B; Sun H; Li Y
    PLoS One; 2013; 8(7):e68525. PubMed ID: 23844215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.
    Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
    Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.
    Xie M; Vesuna F; Tantravedi S; Bol GM; Heerma van Voss MR; Nugent K; Malek R; Gabrielson K; van Diest PJ; Tran PT; Raman V
    Cancer Res; 2016 Nov; 76(21):6340-6350. PubMed ID: 27634756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway.
    Shen L; Zhang J; Xu M; Zheng Y; Wang M; Yang S; Qin B; Li S; Dong L; Dai F
    Int J Biol Sci; 2022; 18(10):3918-3933. PubMed ID: 35844798
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer.
    Heerma van Voss MR; Brilliant JD; Vesuna F; Bol GM; van der Wall E; van Diest PJ; Raman V
    Med Oncol; 2017 Mar; 34(3):33. PubMed ID: 28138868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.
    Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A
    Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
    Bol GM; Vesuna F; Xie M; Zeng J; Aziz K; Gandhi N; Levine A; Irving A; Korz D; Tantravedi S; Heerma van Voss MR; Gabrielson K; Bordt EA; Polster BM; Cope L; van der Groep P; Kondaskar A; Rudek MA; Hosmane RS; van der Wall E; van Diest PJ; Tran PT; Raman V
    EMBO Mol Med; 2015 May; 7(5):648-69. PubMed ID: 25820276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
    Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
    Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
    Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
    Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
    Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
    Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenicity of LHX4 in colorectal cancer through Wnt/β-catenin/TCF4 cascade.
    Cha N; Liu W; Yang N; Xie S; Gao Y; Chen X; Wang X; Ren J
    Tumour Biol; 2014 Oct; 35(10):10319-24. PubMed ID: 25034524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression.
    Guturi KK; Sarkar M; Bhowmik A; Das N; Ghosh MK
    Breast Cancer Res; 2014 Dec; 16(6):496. PubMed ID: 25499975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of DEAD-Box RNA Helicase 3 attenuates stress granule assembly.
    Cui BC; Sikirzhytski V; Aksenova M; Lucius MD; Levon GH; Mack ZT; Pollack C; Odhiambo D; Broude E; Lizarraga SB; Wyatt MD; Shtutman M
    Biochem Pharmacol; 2020 Dec; 182():114280. PubMed ID: 33049245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
    J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.